3Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC)[J]. J Hypertens,2007,25(6) :1105-1187.
4Gerstein HC, Mann JF, Yi Q, etal. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals[J].JAMA,2001,286(4) :421-426.
5GI. Bakris, JR Sowers, American society of hypertension writing group. ASH position paper: treatment of hypertension in patients with diabetes-an update[J]. J Clin Hypertens, 2008,10(9):707- 713.
6Jensen JS, Feldt-Rasmussen B, Strandgaard S, et al. Arterial hypertension, mieroalbuminuria, and risk of isehemic heart disease[J]. Hypertension, 2000,35 ( 4 ) : 898-903.
7Tao J, Jin YF, Yang Z, et al. Reduced arterial elasticity is associated with endothelial dysfunction in persons of advancing age: comparative study of noninvasive pulse wave analysis and laser Doppler blood flow measurement [J]. Am J Hypertens, 2004, 17 (8) :654-659.
8Tap J, Wang Y, Yang Z. Circulating endothelial progenitor cell deficiency contributes to impaired arterial elasticity in persons of advancing age[J]. J Hum Hypertens,2006,20(7) :490-495.
9Cosson E, Pham I, Valensi P, et al. Impaired coronary endothelium-dependent vasodilation is associated with mieroalbuminuria in patients with type 2 diabetes and angiographically normal coronary arteries[J]. Diabetes Care,2006,29(1):107-112.
10Wu AY,Kong NC,De Leon FA,et al.An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients:the Microalbuminuria Prevalence(MAP) Study[J].Diabetologia,2005,48(1):17-26.
